Bio/Pharma News

Allergan Signs Deal with Merck, Acquires Rights to Migraine Development Program

July 07, 2015

The agreement gives Allergan a foothold in migraine drug development.

Horizon Makes Second Offer to Buy Depomed, Gets Rejected Again

July 07, 2015

The offer, valued at $3 billion, represents a 42% increase in Depomed’s share price.

Biogen Plans Biologics Manufacturing Facility in Switzerland

July 06, 2015

Biogen plans to build a biologics manufacturing plant in northwest Switzerland using next-generation technologies to create efficiency and sustainability.

Pfizer’s Once-Daily Arthritis Tablets Accepted for FDA Review

July 06, 2015

FDA has accepted for review Pfizer’s new drug application for its modified-release formulation of tofacitinib citrate tablets (Xeljanz).

CPhI Angels Unveils Charity Initiative to Build Classroom in Kenya

July 01, 2015

CPhI is calling on all its attendees, exhibitors, and the wider pharma community to support this initiative.

DOJ Enters Consent Decree Against Acino Products

July 01, 2015

US Court orders New Jersey drug manufacturer and its president to stop distribution of unapproved and misbranded drugs.

Celgene to Pay $1 Billion for Decade-long Partnership with Juno Therapeutics

June 30, 2015

The partnership will focus on the development of CAR T-cell therapies and other programs related to T-cell technology.

GSK Plans Increase in Antibiotic Production in Singapore

June 30, 2015

GSK will invest in an additional downstream isolation facility for amoxicillin production in Singapore.

Bristol-Myers Squibb Makes Changes in R&D Locations and Focus

June 29, 2015

Bristol-Myers Squibb builds R&D facilities in Massachusetts and San Francisco and discontinues discovery research in virology.

GSK Sells Two Meningitis Vaccines to Pfizer

June 25, 2015

The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.